Angiotensin Ii Enhances Human Macrophage Class A Scavenger Receptor Expression And Induces Foam Cell Formation

Gang Tian,Lu Qun,Lu Min,Zhang Yong,Wang Ya Ping
DOI: https://doi.org/10.1016/j.ijcard.2009.09.014
IF: 4.039
2009-01-01
International Journal of Cardiology
Abstract:Objectives Hypertension is an important risk factor for the development of atherosclerosis. It is associated with an activated tissue rennin–angiotensin system. But the molecular mechanisms for this interaction are incompletely defined. To get insight into a role of the class A scavenger receptor (SR-A) in hypertension enhanced atherosclerotic complications, we have investigated the effects of angiotensin II (Ang II) on SR-A expression and macrophage foam cell formation in cultured human macrophages. Design and methods The human THP-1 monocyte cell line was differentiated into macrophages in vitro and treated with Ang II (10–10 and 10–6 M), or with Ang II (10–8 M) and the angiotensin II type 1 (AT1) receptor blocker Irbesartan (10–5 M) for 24 h in the cells. Foam cell formation was quantified based on percentage of macrophage harboring oil red O-stained globules. SR-A message was measured by competitive reverse transcription-polymerase chain reaction (RT-PCR) and SR-A protein was detected by immunoblot. Results The human macrophages with various concentrations of Ang II enhanced, in a dose-and time-dependent manner, SR-A gene (3.4±0.8-fold by 10-6 M Ang II; P<0.05), and protein (2.8±0.4-fold; P<0.05) expression, reaching their maximum after 24 h incubation (14.3±1.5-fold for gene, P<0.05; 12.6±1.3-fold for protein, P<0.05, respectively); (2) The AT1 receptor blocker Irbesartan prevents these inductions; (3) The increased SR-A expression results in enhancement in the uptake of acetylated low-density lipoprotein (ac-LDL) by an AT1-dependent pathway; (4) Ang II induced human macrophage-derived foam cell formation through a SR-A-dependent pathway. Conclusions These results suggest that Ang II enhances SR-A expression in human macrophages, and that this effect is associated with foam cell formation. The induction of SR-A is mediated by the AT1 receptor. Some of the benefits of AT1 receptor blocker might be explained by their antiatherosclerotic reaction. Objectives Hypertension is an important risk factor for the development of atherosclerosis. It is associated with an activated tissue rennin–angiotensin system. But the molecular mechanisms for this interaction are incompletely defined. To get insight into a role of the class A scavenger receptor (SR-A) in hypertension enhanced atherosclerotic complications, we have investigated the effects of angiotensin II (Ang II) on SR-A expression and macrophage foam cell formation in cultured human macrophages. Design and methods The human THP-1 monocyte cell line was differentiated into macrophages in vitro and treated with Ang II (10–10 and 10–6 M), or with Ang II (10–8 M) and the angiotensin II type 1 (AT1) receptor blocker Irbesartan (10–5 M) for 24 h in the cells. Foam cell formation was quantified based on percentage of macrophage harboring oil red O-stained globules. SR-A message was measured by competitive reverse transcription-polymerase chain reaction (RT-PCR) and SR-A protein was detected by immunoblot. Results The human macrophages with various concentrations of Ang II enhanced, in a dose-and time-dependent manner, SR-A gene (3.4±0.8-fold by 10-6 M Ang II; P<0.05), and protein (2.8±0.4-fold; P<0.05) expression, reaching their maximum after 24 h incubation (14.3±1.5-fold for gene, P<0.05; 12.6±1.3-fold for protein, P<0.05, respectively); (2) The AT1 receptor blocker Irbesartan prevents these inductions; (3) The increased SR-A expression results in enhancement in the uptake of acetylated low-density lipoprotein (ac-LDL) by an AT1-dependent pathway; (4) Ang II induced human macrophage-derived foam cell formation through a SR-A-dependent pathway. Conclusions These results suggest that Ang II enhances SR-A expression in human macrophages, and that this effect is associated with foam cell formation. The induction of SR-A is mediated by the AT1 receptor. Some of the benefits of AT1 receptor blocker might be explained by their antiatherosclerotic reaction.
What problem does this paper attempt to address?